| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.31 | 6e-18 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-16 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-15 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-15 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-12 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |